184 related articles for article (PubMed ID: 9839127)
1. LDL cholesterol and troglitazone therapy.
Howard BV; Howard WJ
Diabetes Care; 1998 Dec; 21(12):2201-3. PubMed ID: 9839127
[No Abstract] [Full Text] [Related]
2. Cardiovascular effects of troglitazone.
Umland EM; Romanelli AM
Ann Pharmacother; 1999 Feb; 33(2):229-32. PubMed ID: 10084419
[No Abstract] [Full Text] [Related]
3. A comparison in a clinical setting of the efficacy and side effects of three thiazolidinediones.
King AB
Diabetes Care; 2000 Apr; 23(4):557. PubMed ID: 10857952
[No Abstract] [Full Text] [Related]
4. Troglitazone directly increases HDL cholesterol levels.
Nozue T; Michishita I; Minagawa F; Genda A
Diabetes Care; 1999 Feb; 22(2):355-6. PubMed ID: 10333957
[No Abstract] [Full Text] [Related]
5. New therapeutic approaches to reversing insulin resistance.
Sonnenberg GE; Kotchen TA
Curr Opin Nephrol Hypertens; 1998 Sep; 7(5):551-5. PubMed ID: 9818203
[TBL] [Abstract][Full Text] [Related]
6. A review of metabolic and cardiovascular effects of oral antidiabetic agents: beyond glucose-level lowering.
Ginsberg H; Plutzky J; Sobel BE
J Cardiovasc Risk; 1999 Oct; 6(5):337-46. PubMed ID: 10534139
[TBL] [Abstract][Full Text] [Related]
7. Troglitazone and small low-density lipoprotein in type 2 diabetes.
Hirano T; Yoshino G; Kazumi T
Ann Intern Med; 1998 Jul; 129(2):162-3. PubMed ID: 9669982
[No Abstract] [Full Text] [Related]
8. The Diabetes Prevention Program.
Muniyappa R; El-Atat F; Aneja A; McFarlane SI
Curr Diab Rep; 2003 Jun; 3(3):221-2. PubMed ID: 12762969
[No Abstract] [Full Text] [Related]
9. Effect of troglitazone in type 2 diabetes mellitus.
Gorson DM
N Engl J Med; 1998 Aug; 339(6):406. PubMed ID: 9696655
[No Abstract] [Full Text] [Related]
10. Effect of troglitazone in type 2 diabetes mellitus.
Rusk MH
N Engl J Med; 1998 Aug; 339(6):406. PubMed ID: 9696656
[No Abstract] [Full Text] [Related]
11. Effect of troglitazone on lipoprotein(a) levels in obese subjects.
Tack CJ; Smits P; DeMacker PN; Stalenhoef AF
Diabetes Care; 1999 Oct; 22(10):1752-3. PubMed ID: 10526754
[No Abstract] [Full Text] [Related]
12. Learning to use troglitazone.
Riddle MC
Diabetes Care; 1998 Sep; 21(9):1389-90. PubMed ID: 9727881
[No Abstract] [Full Text] [Related]
13. [Cardiovascular effects of the thiazolidinedione troglitazone].
Yamada K; Kuzuya H; Nakano T
Nihon Rinsho; 2000 Feb; 58(2):435-9. PubMed ID: 10707572
[TBL] [Abstract][Full Text] [Related]
14. Increase of lipoprotein (a) with troglitazone.
Matsumoto K; Miyake S; Yano M; Ueki Y; Tominaga Y
Lancet; 1997 Dec; 350(9093):1748-9. PubMed ID: 9413470
[No Abstract] [Full Text] [Related]
15. Troglitazone's effect on lipoprotein(a) levels.
Ovalle F; Bell DS
Diabetes Care; 1999 May; 22(5):859-60. PubMed ID: 10332700
[No Abstract] [Full Text] [Related]
16. Troglitazone: a new antihyperglycemic agent.
Vidt DG; Speerhas RA; Reddy SS
Cleve Clin J Med; 1997 May; 64(5):238-40. PubMed ID: 9149473
[TBL] [Abstract][Full Text] [Related]
17. Troglitazone.
Santiago JV
Compr Ther; 1997 Aug; 23(8):560-2. PubMed ID: 9283746
[No Abstract] [Full Text] [Related]
18. Troglitazone: monotherapy indication.
Lisi DM
Arch Intern Med; 1998 Feb; 158(4):412. PubMed ID: 9487241
[No Abstract] [Full Text] [Related]
19. New diabetes drug targets insulin resistance.
Am J Health Syst Pharm; 1997 Mar; 54(6):623, 625. PubMed ID: 9075488
[No Abstract] [Full Text] [Related]
20. Efficacy of troglitazone measured by insulin resistance index.
Nagasaka S; Iwamoto Y; Ishikawa S; Kuzuya T; Saito T
Lancet; 1997 Jul; 350(9072):184. PubMed ID: 9250189
[No Abstract] [Full Text] [Related]
[Next] [New Search]